BlossomHill Therapeutics Inc.

BLSM | NASDAQ

Price Alert Chart Builder DCF Calculator

$26.80

+$1.06 (+4.12%)

At close: Sep 21, 2026, 4:00 PM ET

$26.14

-$0.66 (-2.46%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+4.12%

(1D)

Rating

Updated: Aug 12, 2026

11.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $779.38M

1D Range

25.12 27.99

52W Range

15.25 27.99

Valuation (TTM)

PE -37.22

PB -5.12

EV/EBITDA -31.23

Valuation (NTM)

Forward PE N/A

Forward PEG 1.80

Price Target $33.67

Cash Flow

FCF Yield -2.7%

SBC Adj. FCF Yield -2.7%

SBC Impact -1.5%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y N/A | N/A

FCF 3Y | 5Y N/A | N/A

Returns

ROA -22.0%

ROE 20.7%

ROIC -26.3%

Financial Health

Net Cash

$116M

Current Ratio 7.40

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 20...

Sector Healthcare

Industry Biotechnology

Employees 63

IPO Date Aug 6, 2026

Website www.bhtherapeutics.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$40

Upside

+49.25%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞